Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy ...

Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today reported ...

Announced positive topline data from the Phase 2a RIVER trial in patients with refractory chronic cough (RCC), making Haduvio the first therapy in clinical development ...

In a new case study, researchers from North Carolina State University found Bartonella henselae, Babesia odocoilei and Babesia divergens-like MO-1 DNA in brain tissue samples from a young child with ...

New research shows that key figures in South Africa’s domestic online influence industry are engaged in transnational ...

Received European Commission approval for GOHIBIC® (vilobelimab) for the treatment of SARS-CoV-2-induced acute respiratory distress syndrome ...

While recycling aims to reduce plastic waste, the practice itself could be making matters worse by producing an even more ...

Q4 2024 Earnings Conference Call March 24, 2025 5:00 PM ETCompany ParticipantsGabby Woody - Executive Assistant, ...

Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 million; GraftAssure RUO assay launched July ...

Generations of Americans have grown up using chewing gum, but a new pilot study claims that both synthetic and natural gum ...

Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Full Year 2024 Conference Call. An audio recording of the webcast will be available shortly after the call today on ...

Almonty Industries has continued its strong run, securing a strategic partnership agreement for its tungsten concentrate with ...